Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion type Assertion NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_head.
- NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_provenance.
- NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion evidence source_evidence_literature NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_provenance.
- NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion SIO_000772 17192482 NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_provenance.
- NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion wasDerivedFrom befree-20140225 NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_provenance.
- NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion wasGeneratedBy ECO_0000203 NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_provenance.